Entry Detail



General Information

Database ID:exR0094411
RNA Name:hsa-miR-513a-5p
RNA Type:miRNA
Chromosome:chrX
Starnd:-
Coordinate:
Start Site(bp):147213538End Site(bp):147213555
External Links:hsa-miR-513a-5p



Disease Information

Disease Name:Benign Ovarian Disease
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D010049
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Ovarian Diseases//Disease, Ovarian//Diseases, Ovarian//Ovarian Disease



Expression Detail

GEO ID:GSE106817
Description:Integrated extracellular microRNA profiling for ovarian cancer screening
Experimental Design:Cancer vs Control
Case Disease Type:Benign Ovarian Disease
Case Disease SubType:NA
Case Sample:Benign Ovarian Disease
Control Sample:Non-Cancer
Number of Case:29
Number of Control:2759
Number of Samples:2788





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AEN
chr15
88621337
88632281
+
CD276
chr15
73683966
73714514
+
FAM168B
chr2
131047876
131093460
-
GIPC1
chr19
14477760
14496149
-
IGF2BP3
chr7
23310209
23470491
-
ILF3
chr19
10654261
10692417
+
JRK
chr8
142657460
142681968
-
KCTD21
chr11
78171249
78188626
-
KIAA0232
chr4
6781375
6884170
+
MET
chr7
116672196
116798386
+
MTCL1
chr18
8705661
8832778
+
NRBP1
chr2
27427790
27442259
+
PA2G4
chr12
56104537
56113910
+
PAK1
chr11
77321707
77474635
-
PLK2
chr5
58453982
58460139
-
PPP1CC
chr12
110719680
110742939
-
PRLR
chr5
35048756
35230487
-
RHOU
chr1
228735479
228746664
+
SNX27
chr1
151612006
151699091
+
SOX11
chr2
5692384
5701385
+
SS18
chr18
26016253
26091217
-
STRBP
chr9
123109500
123268586
-
TMX4
chr20
7977346
8019805
-
TXN2
chr22
36467046
36481640
-
WASL
chr7
123681943
123749003
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000894
chr19
12825634
12826553
-
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0001005
chr2
53921020
53978078
-
hsa_circ_0001168
chr20
47691321
47707559
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC009133.5
chr16
29808679
29812227
+
AC023509.1
chr12
53441741
53467528
+
AC095055.1
chr4
151139991
151141103
+
AC239868.1
chr1
149861271
149862504
+
CYTOR
chr2
87454781
87636740
+
KCNQ1OT1
chr11
2608328
2699994
-
LINC01578
chr15
92819540
92899701
+
MIR4435-2HG
chr2
111006015
111523376
-
MIR663AHG
chr20
26167817
26251546
-
NEAT1
chr11
65422774
65445540
+
OIP5-AS1
chr15
41283990
41309737
+
SNHG16
chr17
76557764
76565348
+
SNHG20
chr17
77086716
77099902
+
Display:



Experiment Detail

GEO ID:GSE106817
Sample Source:Blood
Source Fraction:Serum
Platform:GPL21263
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2535
Sample treatment protocol:NA
RNA Extract protocol:Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.).
RNA library preparation protocol:miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.



Reference

PMID:30333487
Title:Integrated extracellular microRNA profiling for ovarian cancer screening
Author:Yokoi A, Matsuzaki J, Yamamoto Y, Yoneoka Y, Takahashi K, Shimizu H, Uehara T, Ishikawa M, Ikeda SI, Sonoda T, Kawauchi J, Takizawa S, Aoki Y, Niida S, Sakamoto H, Kato K, Kato T, Ochiya T
Journal:Nat Commun. 2018 Oct 17;9(1):4319.
Description:to develop an optimal detection method, we use microarrays to obtain comprehensive miRNA profiles from 4046 serum samples, including 428 patients with ovarian tumors.